(Q35270557)

7 August 2017

title

In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents (English)

1 reference

7 August 2017

Khardori N

1

1 reference

7 August 2017

Reuben A

2

1 reference

7 August 2017

Rosenbaum B

3

1 reference

7 August 2017

Rolston K

4

1 reference

7 August 2017

Bodey GP

5

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

1609-1610

1 reference

Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

In Vitro Antibiotic Susceptibility of Pseudomonads Other than Pseudomonas aeruginosa Recovered from Cancer Patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

In vitro evaluation of A-56619 and A-56620, two new quinolones

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-Sulfamethoxazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

Susceptibilities of Pseudomonas Species to Tetracycline, Minocycline, Gentamicin, and Tobramycin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171884

In-vitro susceptibility of Pseudomonas species to fifteen antimicrobial agents

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2221872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.8.1609

1 reference

7 August 2017

1 reference

7 August 2017

1 reference